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Abstract
By employing microcalorimetry to assess overall metabolic activity in combination with other assays for specific
metabolic events, we have investigated the influence of cyclosporin A and FK506 on the metabolic status of resting and
mitogen-stimulated human peripheral lymphocytes. Both cyclosporin A and FK506 significantly reduced heat output from
resting lymphocytes. This reduction could not be correlated with effects on DNA synthesis, lactate production, ATP levels
or mitochondrial uptake of Rhodamine 123. These two drugs also potently reduced the increase in heat output seen during
mitogen stimulation of lymphocytes. Both cyclosporin A and FK506 also prevented the increase in DNA synthesis, lactate
production and ATP levels seen in response to mitogen stimulation. The increase in mitochondrial uptake of Rhodamine
123 during blastoid transformation was significantly reduced only by cyclosporin A. We ascribe the major part of the effects
of these compounds to inhibition of the glycolytic pathway in both resting and mitogen-stimulated lymphocytes. These
results indicate that the immunosuppressants cyclosporin A and FK506 exert other effects on lymphocytes than their
well-established inhibitory action on calcineurin.q 1997 Elsevier Science B.V. All rights reserved.
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1. Introduction
The immunosuppressive compound cyclosporin A
 .CsA has been in clinical use for several years now.
CsA has been shown to be of benefit in the treatment
of allograft rejection, as well as for the treatment of
w xcertain disorders of autoimmune origin 1 . A few
years ago FK506 was isolated from Streptomyces
tsukubaensis. Although structurally unrelated, FK506
and CsA both cause potent suppression of T-cell
)  .  .Corresponding author at address b. Fax: 46 8 15 30 24;
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w xactivation by the same mechanism 2 . When bound
to their respective immunophilins, these two com-
pounds suppress transcription of the gene for IL-2 by
inhibiting the enzymatic activity of calcineurin to-
w xwards NF-AT 3 .
Intensive investigation on the mode of action of
CsA on lymphocytes and on its detrimental effects on
w xother cell-types, e.g., renal cells 4 , have generated a
great deal of information concerning the different
cellular processes affected by this compound. CsA
has been reported to induce mitochondrial dysfunc-
w xtion in rat kidney cells 5 . Furthermore, CsA has
been found to interfere with adenosine metabolism in
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murine B- and T-cells, thus leading to depletion of
w xATP 6 . Similar effects on peripheral rat lympho-
cytes during CsA administration in vivo have also
w xbeen observed 7 .
In addition, CsA has been found to block the
release of mitochondrial matrix proteins through a
Ca2q-requiring pore, indicating beneficial effects of
w xCsA in connection with reperfusion injury 8 . Other
interesting effects of this drug include: depolarization
w xof human peripheral lymphocytes 9 , interference
w xwith plasma membrane phospholipid metabolism 10
w xand induction of cytoplasmic lipid droplets 11 . All
these findings indicate that CsA has a larger number
of biological targets than was believed to be the case
when this drug was originally introduced into clinical
practice.
FK506 has not yet been the subject of such thor-
ough investigation. However, it was recently reported
that FK506, like CsA, also induces respiratory dys-
function of mitochondria from rat kidney cells, but
does not block the CsA-sensitive, Ca2q-dependent
w xpore 12 . FK506 has also been reported to induce
mitochondrial dysfunction in rat enterocytes, thereby
w xincreasing intestinal permeability 13 .
In the present study we have focused our attention
on the effects of FK506 and CsA on resting and
mitogen-stimulated human lymphocytes in vitro, with
special emphasis on the bioenergetic changes these
immunosuppressive compounds may give rise to.
2. Materials and methods
2.1. Chemicals
FK506 and Cyclosporin A were generous gifts
 .from Fujisawa Pharmaceuticals Osaka, Japan and
 .Sandoz Pharma Basel, Switzerland , respectively.
These compounds were dissolved in ethanol 1
.mmolrl in order to obtain stock solutions, from
which aliquots were further diluted in culture medium.
 .Concanavalin A con A was purchased from Phar-
 .  .macia Uppsala, Sweden , propidium iodide PI and
 . Rhodamine 123 R123 from Sigma Chemical St.
. w3 xLouis, MO, USA and H thymidine from Amer-
 .sham Buckinghamshire, UK . All other chemicals
were of analytical grade and obtained from common
commercial sources.
2.2. Cells
Human peripheral blood mononuclear cells were
isolated from the buffy coats of healthy blood donors
The Blood Bank, Sodersjukhuset, Stockholm, Swe-¨
.den by density centrifugation using Lymphoprep
 .Nycomed ArS, Oslo, Norway . The monocytes were
removed from this preparation by allowing them to
adhere to plastic dishes for 60 min. at 378C. The
non-adhering population was )95% lymphocytes,
which were incubated under the different experimen-
tal conditions in RPMI-1640 culture medium supple-
mented with 10% heat-inactivated FCS and 50 mgrml
gentamicin. Cell counting was performed using a
 .Coulter Cell Counter Hialeah, FL, USA .
2.3. Bioacti˝ity monitoring
 .A LKB 2277 Thermal Activity Monitor TAM
 .Thermometric AB, Jarfalla, Sweden of the ther-¨ ¨
mopile heat conduction type was used for measure-
w xment of overall cellular heat production 14 . The
instrument was equipped with three channels and was
kept at 378C. The signal was recorded on two twin-
channel LKB 2210 potentiometric recorders LKB,
.Bromma, Sweden .
The effects of the immunosuppresive drugs CsA
and FK506 on the heat output from resting human
lymphocytes were studied as follows: unstimulated
 6 .cells 10 rml were cultured in medium only or in
medium containing 0.1 mM CsA or FK506 in 75 cm2
plastic bottles for 5 days. Two ml cell suspension
from each flask were transferred to the reaction am-
poule and 2 ml medium to the reference ampoule,
leaving a 3 ml gas-phase. Heat output was then
recorded continuously for the following 24 h.
The steady-state value was normally obtained
within 1 h and was stable throughout the remainder
of the 24-h incubation period. After 24 h, the cells
were removed from the ampoules and counted. New
cells from the flasks were then transferred to the
reaction ampoules and these incubations were re-
peated for five consecutive 24-h intervals.
The inhibitory effect of these drugs on heat output
from proliferating cells was also tested using the
w xcalorimeter, as described previously 15 . In these
experiments 106 cells in 4 ml RPMI were incubated
with 0.1 mM immunosuppressant together with the
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 .mitogen con A 10 mgrml . The cell suspensions
were then immediately transferred to the ampoules,
leaving a 1 ml gas-phase, and inserted into the
calorimeter. The heat output was continuously moni-
tored for the following 60 h.
In the case of con A-stimulated lymphocytes the
values are presented as total heat output from the 106
cells originally incubated in 4 ml medium. The num-
ber of cells in the ampoule after the 60-h incubation
period was still 106.
w xJudging from published values for oxygen 16 and
w xglucose 17 consumption by resting, as well as, by
proliferating lymphocytes, the levels of glucose and
oxygen present during the incubations conducted here
were far from limiting.
2.4. DNA synthesis
w3 xCell growth was monitored as H thymidine in-
w xcorporation, as previously described 18 . One hun-
dred ml medium containing 105 cells were cultured
in 96-well microtiter plates Falcon, Becton Dickin-
.son, Lincoln Park, NJ, USA in 5% CO at 378C. To2
w3 xeach well, 1 mCi H thymidine was added during
w3 xthe last 4 h of incubation. H Thymidine incorpora-
tion in both resting and con A-stimulated cells was
measured for three reasons: to detect any unexpected
activation of the resting cells; to confirm activation of
the cells treated with con A; and to assess and the
effects of CsA and FK506 on DNA synthesis.
2.5. Lactate production
Measurements of the lactate content in the media
from resting and mitogen-stimulated cells, cultured in
a 5% CO -incubator at 378C, were performed using a2
colorimetric procedure performed according to the
manufacturer’s instructions Sigma Chemical, St.
.Louis, MO, USA . Absorption at 540 nm was mea-
sured using an Hitachi U3210 spectrophotometer
 .Tokyo, Japan . Resting or con A-stimulated cells
 6 .were cultured in plastic bottles 10 rml for 96 h.
Once every 24 h, 1 ml of medium was collected,
cleared by centrifugation and stored at y808C for
later analysis of lactate levels.
2.6. ATP assay
The intracellular content of ATP in resting and con
A-stimulated cells was determined using a
luciferase-based luminometric procedure performed
according to the manufacturer’s instructions Bio-
.Orbit, Turku, Finland . Analyses were performed on
an LKB 1250 luminometer and the output recorded
on an LKB 2210 potentiometric recorder LKB,
.Bromma, Sweden . A standard curve was generated
for each set of experiments using a standard ATP
 .solution Bio-Orbit, Turku, Finland .
2.7. Flow cytometry
A FACSCalibur Becton-Dickinson, San Jose, CA,
.USA equipped with a 488 nm air-cooled argon-ion
laser was used for all flow cytometric analyses. Data
from 5000 events were collected for each sample.
Off-line analysis was performed using the CellQuest
 .software Becton-Dickinson, San Jose, CA, USA .
2.8. Mitochondrial membrane potential
To evaluate the effects of drug treatment on mito-
chondrial membrane potential, 106 cells in a 1 ml
suspension were stained with 1 mg Rhodamine 123
 . w xR123 19–21 . Uptake of this dye after a 10-min.
incubation at 378C was measured by flow cytometry.
Resting and con A-stimulated cells were cultured in
 6 .plastic bottles 10 rml for 96 h. Once every 24 h, 1
ml aliquots of cell suspension were removed and
stained with R123.
2.9. Cell ˝iability
Viability was also monitored by flow cytometry
 .using propidium iodide PI to detect the increased
plasma membrane permeability of dead cells, as de-
w xscribed by Sasaki et al. 22 . Cells were stained with
0.5 mg PIrml and analyzed within the subsequent 30
min.
2.10. Expression of antigens associated with acti˝a-
tion
HLA-DR was quantified at certain stages during
the incubations in order to confirm that the resting
lymphocytes had not been activated. A FITC-con-
jugated mouse anti-human HLA-DR monoclonal an-
 .tibody Dakopatts ArS, Glostrup, Denmark was em-
ployed for this purpose.
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2.11. Statistics
Statistical analysis was performed using the alter-
nate Welch t-test.
3. Results
3.1. Calorimetric monitoring of resting and con A-
stimulated cells
Resting lymphocytes demonstrated a heat output of
1.46"0.13 pWrcell after 24 h of incubation Fig.
.1A . This value increased during the first days of
incubation, reaching 2.2"0.3 pWrcell after 72 h
and then declining to 1.73"0.23 after 144 h. FK506-
and CsA-treated cells showed a markedly depressed
heat output in comparison to control cells. After 24 h
of incubation, the heat output from CsA- and
FK506-treated cells were 1.3"0.11 and 1.45"0.22
pWrcell, respectively. These values remained fairly
constant at a level ranging between 1.13 and 1.54
pWrcell. Thus, the heat output from FK506-treated
cells differed significantly from that of untreated cells
after 48, 72 and 96 h of incubation; whereas heat
output from CsA-treated cells was significantly lower
than the control value after 72 and 144 h of incuba-
tion.
Heat-output from con A-stimulated cells after 5 h
of monitoring was 3.13"0.37 mW, while the corre-
sponding values in the prescence of CsA or FK506
were 3.45"0.38 and 2.45"0.15 mW, respectively
 .Fig. 1B . Heat output from the con A-stimulated
cells in the absence of immunosuppressant then grad-
ually increased and reached a maximal value of
11.73"2.03 mW after 55 h of incubation, giving a
net increase of 8.6 mW. Cells treated with CsA,
however, demonstrated their maximal heat output of
4.65"0.64 mW after 45 h, which gives a net in-
 .crease of 1.2 mW 15% of the control increase .
FK506-treated cells also reached their maximal heat
output of 4.1"1.05 mW after 45 h, a net increase of
 .1.65 mW 20% of the control increase .
3.2. DNA synthesis in resting or con A-stimulated
cells
As can be seen from Fig. 2A, no DNA synthesis
could be detected in unstimulated cells or in resting
Fig. 1. Heat output of resting and con A-stimulated lymphocytes
in the absence and presence of CsA or FK506. A: heat output
 6 .  .from resting lymphocytes 2P10 cells in 2 ml of medium I
and lymphocytes incubated in the prescence of 0.1 mmolrl CsA
 .  . v or FK506 e , respectively. B: heat output from con A 10
.  6 .mgrml stimulated lymphocytes 10 cells in 4 ml of medium
 .I and stimulated cells in the prescence of 0.1 mmolrl CsA
 .  .v or FK506, respectively e . The values are means"S.E.M.,
3F nF4. ) Value significantly different from the correspond-
ing control value at the level of P F0.05.
cells treated with FK506 or CsA. As expected, mito-
gen stimulation of the lymphocytes induced DNA
synthesis, reaching a maximal rate of thymidine in-
 .corporation 92500"5700 cpm after 75 h of incuba-
tion. CsA- and FK506-treated cells incorporated only
35% and 33%, respectively, of the control value at
 .this same time-point Fig. 2B .
3.3. Lactate production by resting and con A-stimu-
lated lymphocytes
Untreated cells produced barely detectable amounts
 .of lactate during 96 h of incubation Fig. 3A . When
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Fig. 2. Thymidine incorporation in resting and con A-stimulated
lymphocytes in the absence and presence of CsA or FK506. A:
w3 x  .H thymidine incorporation into resting lymphocytes I and
 .cells in the prescence of 0.1 mmolrl CsA v or 0.1 mmolrl
 . w3 xFK506 e , respectively. B: H thymidine incorporation into con
 .  .A 10 mgrml -stimulated lymphocytes I and stimulated cells
 .in the presence of 0.1 mmolrl CsA v or 0.1 mmolrl FK506
 . )e , respectively. The values are means"S.E.M., 5F nF8.
Values for both CsA- and FK506-treated cells significantly dif-
ferent from the control value at the level of P F0.0001.
lymphocytes were stimulated by mitogen, increasing
amounts of lactate accumulated continuously in the
medium. In mitogen-stimulated cells, the levels of
lactate increased 16-fold between 24 and 96 h of
incubation. In the prescence of FK506, this increase
was 8-fold. CsA was even more potent in this re-
spect, reducing the increase in amount of accumu-
 .lated lactate to only 6.7-fold Fig. 3B .
3.4. ATP le˝els in resting and con A-stimulated cells
Analysis of the cellular ATP content of the resting
cells after 24 h in the calorimeter revealed that
untreated lymphocytes contained 540"37 pmolr106
cells and that this level decreased slightly during the
course of the experiment, being 480"39 pmolr106
cells after 96 h of incubation. Similar results were
obtained with FK506- and CsA-treated cells Fig.
.4A . No major increase in ATP content in response to
con A-stimulation could be detected after 48 h. After
Fig. 3. Lactate release from resting and con A-stimulated lym-
phocytes in the absence and presence of CsA or FK506. A:
 .accumulation of lactate from resting lymphocytes I and rest-
 .ing cells incubated in the prescence of 0.1 mmolrl CsA v or
 .FK506 e , respectively. B: accumulation of lactate from con A
 .  .10 mgrml stimulated lymphocytes I and stimulated cells in
 .  .the prescence of 0.1 mmolrl CsA v or FK506 e , respec-
tively. The values are means"S.E.M., ns3. ) Value signifi-
cantly different from that of the control cells at the level of
P F0.03.
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Fig. 4. ATP contents of resting and con A-stimulated lympho-
cytes in the absence and presence of CsA or FK506. A: ATP
 .contents of resting lymphocytes I and of resting cells incu-
 .  .bated in the presence of 0.1 mmolrl CsA v or FK506 e ,
respectively. B: ATP contents of con A stimulated lymphocytes
 .I and of stimulated cells in the presence of 0.1 mmolrl CsA
 .  .v or FK506 e , respectively. The values are means"S.E.M.,
ns4. ) Value significantly different from that of the control
cells at the level of P F0.006.
72 h of incubation, the ATP contents had increased
 62-fold over the basal level 1020"47 pmolr10
. cells and after 96 h this increase was 4-fold 2350"
6 .  .36 pmolr10 cells Fig. 4B . Treatment with FK506
or CsA clearly reduced this increase in the level of
intracellular ATP. ATP levels in treated and untreated
con A-stimulated cells were similar after 24 h of
incubation. After 72 h of con A-stimulation in the
prescence of CsA or FK506, cellular ATP contents
had still not increased over basal values and were
significantly lower than for the mitogen-stimulated
control cells. After 96 h of con A-stimulation in the
prescence of CsA or FK506, however, the cellular
ATP contents had increased 2-fold and 1.7-fold, re-
spectively, thus still differing from the mitogen-
stimulated control cells in a statistically significant
manner.
3.5. Mitochondrial membrane potential
The distribution of R123 fluorescence in resting
and con A-stimulated cells after 72 h in culture is
shown in Fig. 5. As can be seen, resting cells demon-
strated relatively homogenous fluorescence, with a
single peak containing appproximately 95% of the
 .events M1, Fig. 5A . During mitogen stimulation,
the uptake of R123 increased in some lymphocytes
and, consequently, these cells gave rise to a second
peak with a higher mean fluorescence intensity M2,
. brightFig. 5B . These latter cells are denoted R123 .
The size of the R123bright population is shown in Fig.
6. The size of this population in untreated resting
lymphocytes ranged between 4.1"1.2 and 6.2"
0.17% of the total number of cells during the 96-h
time period studied. Although the size of this popula-
tion increased to 9.6"4.5 and 10.4"3.0% after 96
h in CsA- and FK506-treated cells, respectively Fig.
.6A , these increases were not statistically significant.
During con A-stimulation the size of the R123bright
population rapidly increased to 20.8"2.8% after 24
Fig. 5. R123 fluorescence from resting and con A-stimulated
lymphocytes. A: typical distribution of R123 fluorescence from
resting lymphocytes incubated for 72 h in vitro. The majority of
the cells are recovered within the M1 region. B: typical distribu-
tion of R123 fluorescence from lymphocytes stimulated with con
 .A 10 mgrml for 72 h. Approximately 50% of the cells exhibit
an increase in R123 fluorescence and are found in the M2 region,
referred to as the R123bright population.
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Fig. 6. R123 fluorescence from resting and con A-stimulated
lymphocytes in the absence and presence of CsA or FK506. A:
bright  .size of the R123 population in resting lymphocytes I and
 .in resting cells in the presence of 0.1 mmolrl CsA v or FK506
 . brighte , respectively. B: size of the R123 population in lympho-
 .  .cytes stimulated with con A 10 mgrml I and in stimulated
 .  .cells in the presence of 0.1 mmolrl CsA v or FK506 e ,
respectively. The values are means"S.E.M., ns3. ) Value
significantly different from the control value at the level of
P s0.03.
h of incubation and remained at this level during the
next 24 h. After 72 h of incubation, 41.9"7.1% of
the cells were found in this population and after 96 h
59.6"8.9% of the cells showed increased uptake of
R123. The corresponding values for CsA- and
FK506-treated cells were similar to that of untreated
con A-stimulated lymphocytes during the first 48 h of
incubation. After 72 h, however, the sizes of the
R123bright populations were 26.8"5.7 and 32.1"
6.8% for CsA- and FK506-treated cells, respectively.
These values were not significantly different from the
mitogen-stimulated control cells. After 96 h the cor-
responding values were 31.0"2.5% and 40.6"
 .7.7%, respectively Fig. 6B . Thus, CsA, but not
FK506, significantly reduced the size of the R123bright
population compared to the mitogen-stimulated con-
trol cells after 96 h of incubation.
3.6. Cell ˝iability
The viability of resting lymphocytes, as assesed by
PI staining, was the same for FK506- or CsA-treated
Fig. 7. Uptake of propidium iodide by resting and con A-stimu-
lated lymphocytes in the absence and presence of CsA or FK506.
 .A: uptake of propidium iodide by resting lymphocytes I and
 .by resting cells in the presence of 0.1 mmolrl CsA v or
 .FK506 e , respectively. B: uptake of propidium iodide by
 .  .lymphocytes stimulated with con A 10 mgrml I and by
 .stimulated cells in the presence of 0.1 mmolrl CsA v or
 .FK506 e , respectively. These data are from one representative
experiment of three which gave very similar results.
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cells and control cells. After 24 h of incubation only
1–1.5% of the cells were permeable to the dye and
this value increased to 10.9–11.6% after 96 h Fig.
.7A . Con A stimulation of the cells resulted in a
somewhat lower viability, i.e., 3.2% dead cells after
 .24 h, increasing to 20% after 96 h Fig. 7B . Again,
FK506 and CsA were without effect on the viability
of mitogen-stimulated lymphocytes
3.7. Analysis of acti˝ation of resting cells
Analyses of HLA-DR expression and uptake of
w3 xH thymidine by resting cells were performed in
order to be certain that non-stimulated lymphocytes
were not activated by some other stimulus during the
culture period. Neither of these tests gave any indica-
tion of activation of the resting cells Fig. 2A q data,
.not shown .
4. Discussion
Quiescent lymphocytes have very low metabolic
activity, which is reflected in a low heat production
w xcompared to other cell types 23 . Upon mitogen
stimulation, a number of metabolic processes are
enhanced, leading to an increase in heat output
w x15,24,25 . The most prominent feature is an increase
w xin lactate production 26 , reflecting an increase in the
contribution of glycolysis to overall ATP synthesis
from 4% to 61% after 48 h of mitogen stimulation
w x16 .
Oxidative ATP production, on the other hand, is
not up-regulated during blastogenesis as long as glu-
 . w xcose is available the Crabtree effect 16 . If, how-
ever, glucose is not available, oxygen consumption
increases and the increase in ATP production is
w xtotally accounted for by oxidative pathways 16 .
Even though the oxidative ATP production does not
increase, the mitochondrial uptake of R123 increases
w xduring blastogenesis 27,28 . This may reflect an
increase in mitochondrial mass per cell andror an
increase in mitochondrial membrane potential.
Unexpectedly, we found that heat output from the
untreated resting lymphocytes was significantly ele-
vated after 72 and 96 h compared to the value
obtained after 24 h. A similar finding has also been
w xreported by Gorski and Levin 24 , who found an
increase, although not significant, in heat output from
resting lymphocytes cultured in vitro. We also found
that the elevation of heat production was significantly
prevented by both CsA and FK506.
It is difficult to explain this increase in resting heat
 .production and, consequently, the effect s of the
immunosuppresants, since it was not reflected in any
of the other parameters tested. This is in agreement
w xwith the results of Wang and coworkers 29 , who
could not find any increase in glucose consumption,
lactate production, RNA or DNA synthesis in resting
lymphocytes during 120 h of culture in vitro. Mar-
w xjanovic and coworkers 30 have, however, reported
that glycolytic enzymes were induced in resting lym-
phocytes during 48 h of culture in medium in vitro,
although no increase in lactate production could be
detected. These investigators ascribed this induction
to stimulation of the cells by endogenous serum
factors present in the medium. Addition of con A to
these cells gave, however, no additional induction of
glycolytic enzymes.
Such enzyme induction in resting lymphocytes
may lead to an increased rate of glycolysis, at least in
a subpopulation of the cells, which is reflected in the
rise in heat production. If this is the case, prevention
of this increase in heat production by CsA and FK506
could reflect their ability to interfere with glycolysis.
There are, of course, other exothermic processes that
might be up-regulated in resting lymphocytes, e.g.,
mitochondrial respiration. We have not been able to
find any reports of elevated respiration in resting
lymphocytes during culture in vitro. Other reports
indicate that both CsA and FK506 inhibit mitochon-
w xdrial respiration in other cell types 12,13,31,32 . If
such inhibition also occurs in lymphocytes, this may
explain, at least in part, the decrease in basal heat
output caused by FK506 and CsA, especially in the
light of the fact that oxidative metabolism is the
major source of ATP and heat in resting lymphocytes
w x16,25 .
Here, we could not confirm the reported decrease
in the cellular levels of ATP upon CsA treatment of
w xnon-stimulated lymphocytes 6,7 . This discrepancy
may be explained by the very different conditions
used by these other investigators.
Human lymphocytes responded with a profound
 6increase in heat output from 3 mW to 12 mWr10
.cells after 55 h of con A stimulation. In contrast, the
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heat output from CsA- and FK506-treated con A-
stimulated cells did not increase much above the
initial value during the entire incubation period in the
calorimeter. The increases in DNA synthesis and
intracellular ATP content in con A-stimulated lym-
phocytes came after the increase in heat output.
These findings confirm the results of Yamamura and
w xcoworkers 33 , who used calorimetry to monitor heat
output during the cell cycle of a synchronized mouse
breast cancer cell line. These investigators found that
heat output increased throughout the G1, S and G2
phases, followed by a rapid decrease as soon as the
cells entered the M phase and the cell number started
to increase.
Lactate production in con A-stimulated lympho-
cytes was also depressed by both CsA and FK506,
with CsA being more potent in this respect. There are
obviously different mechanisms controlling glycoly-
sis in different cell types, since lactate production by
the rat enterocytes studied by Madsen and coworkers
w xwas totally unaffected by FK506 13 . The findings of
w xWollberg and Nelson 34 , on the other hand, agree
with ours, since these investigators found FK506 to
inhibit enolase and LDH isozymes in mitogen-stimu-
lated lymphocytes. CsA has also been reported to
interfere with glucose metabolism in lymphocytes,
antagonizing the effects of phenylephrine, but having
no effect on lactate production itself in resting cells
w x35 .
Our results on mitochondrial membrane potential
w xconfirm the findings of Koponen and coworkers 28 ,
who observed a decrease in mitochondrial uptake of
R123 during treatment of mitogen-stimulated lym-
phocytes with CsA. However, in the present study,
FK506 did not significantly reduce the increase in
R123 uptake associated with mitogen stimulation.
Our data indicate that CsA and FK506 both inhibit
the induction of glycolysis caused by mitogen stimu-
lation of lymphocytes as well as, possibly, in resting
cells; and that it is this inhibitory effect that is
reflected in the smaller increases in heat output, DNA
synthesis, lactate production and ATP content. Of
course, the possibility remains that the effects on
resting cells may involve alterations in oxidative
phosphorylation, especially in the light of the fact
that lactate production in these cells is apparently not
affected by exposure to CsA or FK506, although
these measurements were close to the limit of detec-
tion for this assay. The depression of overall
metabolism from the resting cells by these com-
pounds, as measured by microcalorimetry, may re-
flect inhibition of different exothermic processes not
possible to identify with specific assays. Induction of
glycolytic enzymes and an increase in aerobic glycol-
ysis have been found to be more or less a prerequisite
w xfor DNA synthesis 29 . We and others have also
found that inhibitors of glycolysis impair the lympho-
cytic response to mitogen to a much larger extent
than do inhibitors of mitochondrial respiration, fur-
ther illustrating the importance of the glycolytic path-
w xway during lymphocyte stimulation 26,36 .
Since little information is available on the mecha-
nisms underlying the induction of these metabolic
events in mitogen-stimulated lymphocytes, we cannot
say whether the inhibition of calcineurin by these two
immunosuppressive drugs is involved in their effects
on the metabolic parameters monitored here. These
effects may also reflect a separate chain of events,
involving an inhibitory action of these drugs on the
 .as-yet-elusive natural cellular role s for the im-
w xmunophilins 8,37–41 .
In conclusion, there would seem to be many,
as-yet-unidentified cellular events which are affected
by CsA and FK506. Further research will provide
information which may also allow us to explain the
side-effects of these drugs, thereby providing a basis
for selecting the treatment of choice in clinical prac-
tice.
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